Purchase Order FA460015P0063
- Not listed
- Abbott Laboratories Inc., through its Abbott Diagnostics Division, received a $705.84K firm fixed-price purchase order from the Defense Health Agency on September 27, 2024, for delivery by September 30, 2025. The contract covers two analyzer platforms capable of performing chemistry and immunoassay testing at Travis Air Force Base in Fairfield, California. The system includes automation capabilities for specimen handling, including loading, transporting, decapping, sealing, and archiving...
- This delivery order, awarded October 1, 2022, to Abbott Laboratories Inc.'s Abbott Diagnostics Division, procures a chemistry analyzer in response to GSA RFQ #1590614 with a firm fixed-price ceiling value of $649,490.59. The order is expected to reach ultimate completion by April 30, 2026, and will be performed at Scott Air Force Base in Illinois. Funding derives from the Air Mobility Command, a major command within the U.S. Department of Defense responsible for global airlift, air refueling,...
- This federal contract award is for Chemistry Analyzers, made by Abbott Laboratories Inc. under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration (GSA) Federal Supply Schedule contract. The $163,665.65 firm fixed-price delivery order was awarded by the U.S. Air Force's Air Combat Command on October 1, 2015, with a performance period ending on September 30, 2016. The contract does not have a set-aside designation. Abbott Laboratories, a global healthcare company, is...
- Abbott Laboratories Inc., Abbott Diagnostics Division has been awarded a $3.7 million firm fixed price delivery order against the Department of Defense's Critical Analyzers, Laboratory GSA Schedule to provide chemistry lab analyzers and testing services to Travis Air Force Base in Fairfield, California. Under this three-year contract, Abbott will supply the Air Force's 60th Medical Group with laboratory equipment and conduct cost per test analysis to support the medical wing's patient care...
- This federal contract award to Abbott Laboratories Inc. (Abbott), a subsidiary of Abbott Laboratories, is for the delivery of REAGENTS under a GSA Federal Supply Schedule contract for Critical Analyzers, Laboratory (FSS-66-III). The $191,754.44 fixed-price contract was awarded on October 1, 2016 by the U.S. Air Force's Air Combat Command and has an ultimate completion date of September 30, 2017. This order was not set aside for any small business designation. Abbott Laboratories is a large,...
- Abbott Laboratories Inc., through its Abbott Diagnostics Division, was awarded a Delivery Order contract by the Defense Health Agency for chemistry and immunoassay analyzer testing services at Travis Air Force Base in Fairfield, California. This Firm Fixed Price contract, with a ceiling value of $814,369.87 and an ultimate completion date of September 26, 2026, requires Abbott to provide comprehensive management, instrumentation, reagents, quality control materials, consumable parts,...
- Abbott Laboratories Inc., through its Abbott Diagnostics Division, was awarded a delivery order valued at $48.4 million by the Defense Health Agency for the procurement of two chemistry and immunoassay analyzers and one laboratory automation system. This firm fixed-price delivery order, with an ultimate completion date of December 31, 2025, supports clinical laboratory operations at Portsmouth, Virginia. The award was made without set-aside designation through full and open competition and is...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order on August 28, 2025, for a blood chemistry analyzer with a fixed ceiling value of $8,297.48. The contract utilizes a fixed-price pricing structure with economic price adjustment provisions and is set to conclude by August 29, 2025. This delivery order is issued without set-aside designation, indicating full and open competition. The place of performance is North Chicago, Illinois, which aligns with...
- Abbott Laboratories Inc., through its Abbott Diagnostics Division, was awarded a delivery order valued at $40,500.49 by the Defense Health Agency on April 1, 2025, with an ultimate completion date of April 30, 2025. This firm fixed-price contract supports the FY25 funds increase for the CPRR Automated Core Lab and will be performed at Abbott's North Chicago, Illinois facility. The award was made without a set-aside designation, indicating full and open competition. This delivery order is...
- This federal contract award is for an Immunochemistry Analyzer system, with a cost per test pricing structure, awarded by the Air Mobility Command (AMC) under the GSA Federal Supply Schedule 66-III for Critical Analyzers, Laboratory. The prime contractor is Abbott Laboratories Inc., through its Abbott Diagnostics Division, which has extensive experience providing a range of medical devices, diagnostic products, and associated services to various U.S. federal agencies. The contract, valued at...
Abbott Laboratories Inc., through its Abbott Diagnostics Division, was awarded a purchase order valued at $731,234.88 by Air Combat Command (ACC) for a chemistry analyzer base year requirement at Offutt Air Force Base, Nebraska. The firm fixed-price contract, awarded on September 3, 2015, was extended for two additional months under Federal Acquisition Regulation (FAR) clause 49 CFR 53.217-8 to accommodate a longer-than-expected installation timeline for the new equipment and to address procurement protest proceedings. No small business set-aside designation was used, indicating full and open competition for this requirement. This award reflects Abbott Diagnostics' established capability as a supplier of advanced clinical laboratory equipment and services to federal defense and healthcare organizations. The chemistry analyzer procurement supports ACC's medical testing and clinical laboratory operations, consistent with the company's extensive portfolio of diagnostic equipment and reagent supply contracts across the Department of Defense and Veterans Affairs. The contract's ultimate completion date was February 28, 2020, representing the conclusion of the base year plus extension period for this medical equipment acquisition.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Chemistry Analyzer | Department of the Air Force Air Combat Command | Limited / Sole Source Justification 1/1 | 10/16/19, 12:53 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00008 | Exercise an Option | $26.1k | 10/15/19 | |
| P00007 | Exercise an Option | $13.1k | 8/29/19 | |
| P00006 | Other Administrative Action | $0 | 11/19/18 | |
| P00005 | Exercise an Option | $156.6k | 7/30/18 | |
| P00004 | Supplemental Agreement for work within scope | $26.4k | 9/15/17 |